Latest Regulatory News

WhiteHawk Limited has raised A$1.5 million through a share placement to fund integration and growth of its newly acquired Quixxi Clarity AI platform, marking a strategic push into the AI governance market.

Magnum Mining names Antonio Vitor Junior as Managing Director to spearhead major drilling campaigns at its Azimuth and Parker projects, aiming to convert promising early rare earth results into a formal resource.

Xenitra Limited has acquired Hong Kong Fukang Trading Co., including key pharmaceutical licenses and ecommerce assets, to fully operationalise its OTC medicine business in Hong Kong and China.

EV Resources has confirmed a large-scale, shallow carbonate replacement deposit (CRD) antimony system at its Los Lirios project in Mexico, with 10 of 11 drill holes intersecting the mineralised limestone unit. The system extends over a 400m strike and remains open in multiple directions, advancing the company towards a maiden JORC resource estimate.

Shine Justice reshuffles its top management as Simon Morrison steps down from Managing Director to Executive Director to spearhead international growth, particularly in its burgeoning mass torts program, while Carolyn Barker AM maintains overall CEO leadership.

Orthocell has secured approval for its Remplir™ nerve repair device to be used across 221 U.S. military and veterans hospitals, marking a major step in its U.S. commercial expansion. The approval follows clinical validation in conflict zones, positioning Orthocell to deepen penetration into defence healthcare.

AusQuest gears up for maiden drilling at two promising copper-gold prospects in Peru, aiming to build on the momentum from its Cangallo discovery. Over 8,000 metres of Reverse Circulation drilling are set to test high-priority IOCG and porphyry targets starting Q2 2026.

Terrain Minerals’ latest drilling at its Lightning Gold Prospect reveals continuous high-grade gold mineralisation, expanding the system’s footprint and complexity. With a mining lease granted and a maiden JORC resource estimate due mid-year, the project is poised for a pivotal phase.

Nyrada has secured ethics approval to start its Phase IIa trial of Xolatryp in heart attack patients, with recruitment beginning in April 2026. The biotech also bolsters its cash position to AU$6.74 million and pursues new oncology indications.

Tivan and Sumitomo Corporation have extended their Memorandum of Understanding for the Molyhil Tungsten Project to June 2026, allowing Tivan to complete a Scoping Study and progress joint venture negotiations. Drilling has commenced to expand the resource base, with product marketing underway targeting Q3 2026 delivery.

National Storage REIT securityholders have overwhelmingly approved the Brookfield-GIC consortium's $2.86 per security cash acquisition, paving the way for a $6.7 billion transaction expected to complete in May 2026.

Vysarn Limited's joint venture with Kariyarra Aboriginal Corporation has been shortlisted by Water Corporation to submit a formal proposal for supplying bulk water to Port Hedland, progressing key regulatory approvals for the Kariyarra Water Scheme.